ACE Incubator
ACE Incubator is a university startup incubator based in Amsterdam, jointly owned by four academic institutions: the University of Amsterdam, Vrije Universiteit, Hogeschool van Amsterdam, and Amsterdam UMC. It is dedicated to supporting researchers, scientists, students, and entrepreneurs with technology-driven ideas, helping them transform their concepts into viable businesses. The incubator hosts young entrepreneurs who are developing innovative solutions in sectors such as deep tech, medical and health technology, chemical and advanced materials, and sustainable technology. ACE provides a range of resources, including tailored programs, startup facilities, an extensive entrepreneurial network, and mentorship from experienced startup professionals, thereby facilitating the growth of ambitious science and high-tech entrepreneurs at all stages of their business journey.
Dyme
Pre Seed Round in 2018
Dyme B.V. is a company based in Amsterdam, Netherlands, founded in 2018. It has developed a mobile application that consolidates users' subscriptions, allowing them to manage, cancel, and switch services efficiently. The app serves as a smart savings platform, providing users with a comprehensive overview of their income and expenses. By leveraging financial data and machine learning technologies, Dyme's platform offers insights into personal finances and aids in the renegotiation of ongoing contracts, enabling users to reduce their fixed expenses and save money.
Aiir Innovations
Pre Seed Round in 2016
Aiir Innovations B.V., founded in 2016 and based in Amsterdam, specializes in developing software solutions that enhance industrial processes through artificial intelligence and computer vision. The company focuses on automating borescope inspection analysis, which significantly improves the efficiency and quality of visual inspections in the aviation sector. Their software analyzes video footage and images to assist inspection teams, enabling them to identify anomalies such as cracks and dents in aircraft engines. This automation allows mechanics to concentrate on assessing damage rather than the inspection process itself, ultimately contributing to safer aircraft operations. Aiir Innovations aims to broaden the application of its technology beyond aviation, enhancing maintenance practices across various industries.
Hep-Art Medical Devices
Pre Seed Round in 2015
Hep-Art Medical Devices B.V. is a spin-off from the Academic Medical Center in Amsterdam, focused on developing innovative solutions for acute liver failure (ALF) patients. The company's primary product, the AMC-BAL, is a bio-artificial liver system designed to support patients during liver recovery or until a donor liver becomes available. This extracorporeal device functions by treating the patient's plasma and temporarily replacing essential liver functions. Central to the AMC-BAL is a bioreactor that contains embedded liver cells, specifically porcine hepatocytes. Initial clinical trials have demonstrated the safety of this system in ALF patients, marking a significant advancement in the treatment options available for those with acute liver conditions.
NICO.LAB
Pre Seed Round in 2014
Born from the MRCLEAN trial, NICO.LAB was founded in 2015 as a spin-off from the Amsterdam University Medical Center. Our research background continues to drive our way of thinking. The team consists of researchers, developers and experienced medical specialists to ensure we align with our clients needs. We believe connecting human & artificial intelligence will revolutionize emergency care. Our cloud-based solution, StrokeViewer, automatically analyses brain CT scans and gives results within minutes. StrokeViewer empowers physicians in the emergency setting to provide patients with the right treatment in time.
InCatT
Pre Seed Round in 2014
InCatT B.V., or Innovative Catalyst Technologies, is a spin-off from the homogeneous catalysis group led by Prof. Dr. Joost Reek at the University of Amsterdam. The company operates as a contract research organization specializing in catalyst development for various chemical processes. InCatT focuses on enhancing catalytic processes through high throughput screening, catalyst optimization, and scale-up studies. It offers a selection of ligands, including UreaPhos and MetamorPhos, designed for asymmetric catalysis. By providing innovative solutions, InCatT assists clients in addressing catalyst challenges across multiple sectors, including pharmaceuticals, flavor and fragrance, oil and gas, and fine chemicals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.